Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03394261 · ClinicalTrials.gov registry record · NA

Pilot Test of Patient Decision Aid for Opioid Use Disorder

A NA study of Opioid Use Disorder, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT03394261 is a NA study of Opioid Use Disorder that has completed, run by University of California, Los Angeles. The registered enrollment target is 72 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03394261, a NA study of Opioid Use Disorder, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

The aims of the current study phase (R21) are: Aim 1. Develop a patient decision aid (PtDA-MAT) by incorporating best available scientific evidence on MAT as well as feedback from patients and clinical providers related to clinical priorities, perceived utility, and acceptability; Aim 2. Conduct pilot testing of the PtDA-MAT in an iterative process guided by an expert panel and involving key stakeholders (e.g., patients, physicians, policymakers) and field-testing.

Conditions Studied

Interventions

  • BEHAVIORAL Patient Decision Aid

Study Locations (1)

California

  • Tarzana Treatment Centers, Inc. - Tarzana

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2018-06-14
Est. Completion 2018-12-21
Phase NA

What the Registry Record Tells You About NCT03394261

The ClinicalTrials.gov registry entry for NCT03394261 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (98% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Patient Decision Aid is the first listed.

NCT03394261 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03394261 about?

NCT03394261 is a clinical study titled "Pilot Test of Patient Decision Aid for Opioid Use Disorder". The aims of the current study phase (R21) are: Aim 1. Develop a patient decision aid (PtDA-MAT) by incorporating best available scientific evidence on MAT as well as feedback from patients and clinical providers related to clinical priorities, perceived utility, and acceptability; Aim 2. Conduct pil...

What is the current status of trial NCT03394261?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2018-06-14. Estimated completion is 2018-12-21.

What conditions does trial NCT03394261 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT03394261?

The interventions under investigation include: Patient Decision Aid (BEHAVIORAL).

Who is sponsoring clinical trial NCT03394261?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03394261 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.